AQST - Aquestive Therapeutics slumps 13% prices $75M offering March, 20 2024 03:37 AM Aquestive Therapeutics Inc. 2024-03-20 03:37:53 ET More on Aquestive Therapeutics Aquestive Therapeutics: Anaphylm's Top-Line Data Could Reveal A Game-Changer In Q1 Aquestive Therapeutics reports mixed Q4 results; initiates FY24 outlook Seeking Alpha’s Quant Rating on Aquestive Therapeutics For further details see: Aquestive Therapeutics slumps 13%, prices $75M offering